Last reviewed · How we verify
NCT06299345
The Effect of Motor Imagery Dosage on Motor Learning in Healthy Adults
NA trial testing Motor imagery training in Healthy in 27 participants. Completed in 28 April 2022.
20 April 2022
Quick facts
| Lead sponsor | Ahmed Mahmoud Kadry |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 27 |
| Start date | 1 March 2022 |
| Primary completion | 20 April 2022 |
| Estimated completion | 28 April 2022 |
| Sites | 2 locations across United States, Egypt |
Drugs / interventions tested
- Motor imagery training
- NO motor imagery training
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Ahmed Mahmoud Kadry
Who can join
Adults 18 to 35, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare the effects of different durations of Motor Imagery (MI) practice and physical practice on motor performance enhancement in healthy adults. The main questions it aims to answer are: * Does Motor Imagery (MI) practice improve motor performance? * How do different doses of MI practice (low vs. high) compare to no MI practice in enhancing motor performance? Participants: * Be randomly assigned to one of three groups: no MI practice (control group), low dose MI practice (6 minutes per session), or high dose MI practice (12 minutes per session). * Complete nine sessions over three weeks, practicing a timed mirror tracing task. * Have their performance measured in each session by the time taken to complete the task and the number of errors made. Compared the control group, low dose MI group, and high dose MI group to see if there are significant differences in motor performance enhancement, aiming to determine the effectiveness of MI and the optimal dose for practice.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The Effect of Motor Imagery Dosage on Motor Learning in Healthy Adults: A Pilot Study.
Zakadan PS, Kadry AM, Zope Y, Alharthi MA, et al · · 2024 · DOI 10.21203/rs.3.rs-4299962/v1
Verify or expand the search:
- PubMed search for NCT06299345
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motor imagery training
Trials testing the same drug.
- NCT07327190 — Motor Imagery and Action Observation Training in Total Knee Arthroplasty: A Randomized Controlled Trial · NA · active not recruiting
- NCT05168033 — Motor Imagery After Reconstruction of the Anterior Cruciate Ligament · NA · unknown
- NCT03098927 — Mirror Neuron Network Based Motor Imagery Training to Improve Brain Computer Interface Performance in Spinal Cord Injury · NA · withdrawn
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06299345 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahmed Mahmoud Kadry
- Last refreshed: 12 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06299345.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing